Dem senators ask drug companies to list prices in ads

Dem senators ask drug companies to list prices in ads

A group of mostly Democratic senators is urging eight major drug companies to include the price of their drugs in advertisements, a measure that President TrumpDonald John TrumpEx-ethics chief calls on Trump to end 'monstrous' migrant policies Laura Bush blasts Trump migrant policy as 'cruel' and 'immoral' US denies report of coalition airstrike on Syria MORE endorsed last week in his drug-pricing blueprint.

“We are pleased that the President recently acknowledged the importance of requiring price disclosure on direct-to-consumer ads—it is our hope that he will actually follow through,” Sens. Dick DurbinRichard (Dick) Joseph DurbinHugh Hewitt to Trump: 'It is 100 percent wrong to separate border-crossing families' Opioid treatment plans must include a trauma-informed approach Overnight Health Care — Sponsored by PCMA — Dems want answers on DOJ ObamaCare decision MORE (D-Ill.), Kirsten GillibrandKirsten Elizabeth GillibrandCongress must confront sexual abuse of military children The Hill's Morning Report — Can the economy help Republicans buck political history in 2018? Sanders gets best reception at early 2020 audition MORE (D-N.Y.), Maggie HassanMargaret (Maggie) HassanOvernight Health Care — Sponsored by PCMA — Health chief grilled on Trump drug pricing plan, ObamaCare case Health chief: Decision not to defend ObamaCare in court not a 'policy' position Overnight Health Care — Sponsored by PCMA — VA reform bill heads to Trump's desk MORE (D-N.H.), Sherrod BrownSherrod Campbell BrownPence knocks Sherrod Brown in Ohio, boosts Renacci On The Money: Trump imposes B in tariffs on China | China blasts 'fickle' Trump, promises payback | Trump to name consumer bureau director next week Bank regulator faces backlash over comments on racism MORE (D-Ohio) and Angus KingAngus Stanley KingHillicon Valley: Judge approves AT&T-Time Warner deal in blow to DOJ | Dems renew push to secure state voting systems | Seattle reverses course on tax after Amazon backlash | Trump, senators headed for cyber clash | More Tesla layoffs Trump, senators headed for clash on cyber policy For .2 billion, taxpayers should get more than Congress’s trial balloons MORE (I-Maine) wrote to the drug companies.

“As an honest first step to the American public, we urge you to immediately and voluntarily commit to transparency and disclose the price of your prescription drugs in direct-to-consumer advertisements,” the letter sent Friday states.

ADVERTISEMENT

The letter was sent to major pharmaceutical companies such as Eli Lilly, Novartis and Pfizer. 

Trump released a plan last week directing the Food and Drug Administration to study the possibility of including the list prices of drugs in direct-to-consumer advertising. The measure was part of Trump's blueprint aimed at lowering prescription drug costs.

Durbin introduced a bill last year that would require a similar disclosure of drug prices.

While pharmaceutical companies have to include warnings and side effects for drugs in television advertisements, they currently do not have to include prices.

Some have voiced concerns that including the list price of drugs could confuse consumers or deter them from purchasing the product, since the price at a pharmacy is often much lower if the individual has health insurance.

At an event with reporters Tuesday, Lori Reilly, an executive vice president of the Pharmaceutical Research and Manufacturers of America (PhRMA), discussed the issue of forcing companies to include the price of drugs in ads, arguing "it’s an open question about whether or not it’s constitutional.”

This post was updated at 4 p.m.